Languages
  • Deutsch
    •
  • Español
  • français
    •
  • русский
    •
  • العربية
    •
    info@iozk.de
    • Deutsch Deutsch German de
    • English English English en
    • Español Español Spanish es
    • Русский Русский Russian ru
    IOZK
    • Home
    • The IOZK
      • Philosophy
      • Team
      • Treatment Center
      • Laboratories
      • Directions and Accommodation
      • Patients Pamphlet
    • The IOZK Immunotherapy
      • IOZK Immunotherapy
      • The Vaccine IO-VAC®
      • The Treatment
      • IOZK Immunotherapy for Different Types of Cancer
      • Therapy Costs
      • FAQ
    • Expert Knowledge
      • IOZK Publications
      • Publications
      • Interesting Facts
    • News
    • Contact
    • Search
    • Menu

    New Posts

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences2023-01-23 - 16:16
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi2020-02-10 - 13:14
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 20192019-07-14 - 12:11

    SPECIALISTS IN IMMUNO-ONCOLOGY

    Interesting Facts

    • Evidence Based Medicine2023-02-01 - 10:15
    • IOZK Laboratories2020-04-29 - 09:03
    • Warmth against Cancer: Therapeutic Hyperthermia2019-06-24 - 14:20
    • What is Immunotherapy?2019-06-24 - 14:18
    • Personalized Medicine in Oncology2019-06-24 - 14:17
    • Viruses Against Cancer: Oncolytic Virotherapy2019-06-24 - 13:53
    • Dendritic Cells Inform the Immune System2019-06-19 - 12:56
    • The Development of Cancer2019-06-19 - 12:52
    • Nobel Prizes for Immunotherapy2019-06-19 - 09:25

    Tags

    Brain Tumor Checkpoint Inhibitors Chemotherapy Dendritic Cells Dr. Wilfried Stücker Hyperthermia Immunotherapy IO-Vac IOZK-Symposium IOZK Immunotherapy IOZK Team of Experts Liquid Biopsy Newcastle Disease Virus Nobel Prize in Medicine Oncology Oncolytic Viruses Paul Ehrlich Award Personalized Medicine Pontine Glioma Prof. Dr. rer. nat. Volker Schirrmacher Prostate Cancer Publications by Stefaan Van Gool MD. PhD. Stefaan Van Gool MD. PhD. Target Therapy Virotherapy
    IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
    Hohenstaufenring 30–32
    50674 Cologne | Germany

    T: +49 (0)221 – 420 399 25
    F: +49(0)221 - 420 399 26
    E-Mail: info@iozk.de

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    The IOZK Immunotherapy

    • IOZK Immunotherapy
    • The Vaccine IO-VAC®
    • The Treatment
    • IOZK Immunotherapy for Different Types of Cancer
    • Therapy Costs
    • FAQ

    News

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    © 2019 IOZK Immun-Onkologisches Zentrum Köln
    • Privacy Statement
    • Cookie Settings
    Scroll to top